REGENXBIO Inc.
RGNX· Nasdaq
RGNXREGENXBIO Inc.
Filed Aug 9, 2016 · 10-Q · 40 days after period end · 0001564590-16-023492
| Metric | Q2 2016 | Q2 2015 | Q2 2014 |
|---|---|---|---|
| Revenue | $2.38M | $1.36M | $1.55M |
| Net Income | -$14.44M | -$6.29M | -$672.00K |
| EPS Diluted | -$0.55 | -$3.24 | -$0.34 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
REGENXBIO Inc. · CIK 1590877 · Engraved from SEC EDGAR
ended Jun 30, 2016 · filed Aug 9, 2016 · 40 d after period end
